Literature DB >> 12032121

Use of insulin glargine during pregnancy in a type 1 diabetic woman.

John T Devlin, Loretta Hothersall, J L Wilkis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12032121     DOI： 10.2337/diacare.25.6.1095-a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  The insulin analog glargine during an unplanned pregnancy.

Authors:  Daniela Cechurová; Silvie Lacigová; Zdenĕk Jankovec; Iva Haladová; Michal Zourek; Michal Krcma; Zdenĕk Rusavý; Jirí Turek
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

2.  Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Authors:  E Boix; P Zapater; A Picó; O Moreno
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

Review 3.  Insulin glargine in the treatment of type 1 and type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2006

4.  Perinatal outcomes associated with the use of glargine during pregnancy.

Authors:  G Di Cianni; E Torlone; C Lencioni; M Bonomo; A Di Benedetto; A Napoli; E Vitacolonna; D Mannino; A Lapolla
Journal:  Diabet Med       Date:  2008-08       Impact factor: 4.359

Review 5.  A review of current treatment strategies for gestational diabetes mellitus.

Authors:  Kristi W Kelley; Dana G Carroll; Allison Meyer
Journal:  Drugs Context       Date:  2015-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.